Researchers shed light on T-cell receptor activation in response to infection
Immune cells specialize to ensure the most efficient defense against viruses and other pathogens. Researchers at the University of Basel […]
WEDNESDAY, Dec. 9, 2020 — Axicabtagene ciloleucel (axi-cel), an autologous anti-CD19 chimeric antigen receptor T-cell therapy, is promising for the […]T-Cell
ASH: CAR T-Cell Therapy Promising for Relapsed/Refractory iNHL